Navigation Links
Previous Claims of siRNA Therapeutic Effects Called into Question by Report in 'Human Gene Therapy'
Date:9/2/2008

ing a mouse model of influenza, the authors demonstrated that the anti-viral activity of siRNA is mainly due to non-specific stimulation of the immune system rather than to a targeted attack on the disease-causing virus.

"siRNA holds tremendous potential as a research tool, however its clinical development is still in its infancy. The study by Robbins et al. points out a very important issue regarding non-specific effects that should be considered when designing and evaluating siRNA strategies," says James M. Wilson, MD, PhD, Editor-in-Chief, and Head of the Gene Therapy Program, Division of Medical Genetics, University of Pennsylvania School of Medicine, in Philadelphia.

'Human Gene Therapy,' the Official Journal of the European Society of Gene and Cell Therapy (http://www.esgct.org), the British Society for Gene Therapy (http://www.bsgt.org), and the French Society of Cell and Gene Therapy (http://www.sftcg.fr), is an authoritative peer-reviewed journal published monthly in print and online that presents reports on the transfer and expression of genes in mammals, including humans. Related topics include improvements in vector development, delivery systems, and animal models, particularly in the areas of cancer, heart disease, viral disease, genetic disease, and neurological disease, as well as ethical, legal, and regulatory issues related to the gene transfer in humans. Tables of contents and a free sample issue may be viewed online at http://www.liebertpub.com

Mary Ann Liebert, Inc (http://www.liebertpub.com) is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including 'Tissu
'/>"/>

SOURCE Mary Ann Liebert, Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
2. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
3. Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy
4. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
5. CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
6. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
7. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
8. ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies
9. Results Published in the Journal Cancer Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
10. Pressure Cycling Technology (PCT) Results in a Higher Yield of Proteins and in the Extraction of Proteins Not Previously Identified in Cancer, Stroke, and IVF Studies
11. Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...NEW YORK, Nov. 20 Reportlinker.com...ailable in its catalogue. ,, Global Markets fo...://www.reportlinker.com/p0164742/Global-Markets-fo...ce=prnewswire&utm_medium=pr&utm_campaign=p...oduction covers the U.S., 15 Countries in Europe a...
(Date:11/20/2009)...USTON, Nov. 20 Cyberonic...Moore, President and Chief Executive Officer, and ... at the 21st Annual Piper Jaffray Health Care Conf...at 12:00 PM EST. The conference session and webca... presented. Piper Jaffray will host a webcast of ...
(Date:11/20/2009)...NCETON, N.J., Nov. 20 So...x or the Company), formerly known as DOR BioPharma...ced today that it has formed a consortium to devel...d other rapidly acting vaccines. Soligenix receive... of Allergy and Infectious Diseases (NIAID), a div...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Boston Medical Center Selects Bank of America to Assist with Payments Transformation 47783 1Boston Medical Center Selects Bank of America to Assist with Payments Transformation 47783 2Boston Medical Center Selects Bank of America to Assist with Payments Transformation 47783 3National Infertility Organization Honors RMA of New York for Community Support 47782 1National Infertility Organization Honors RMA of New York for Community Support 47782 2Guardian Survey Reveals Widespread Lack of Understanding of Health Savings Accounts 47779 1Guardian Survey Reveals Widespread Lack of Understanding of Health Savings Accounts 47779 2Guardian Survey Reveals Widespread Lack of Understanding of Health Savings Accounts 47779 3Guardian Survey Reveals Widespread Lack of Understanding of Health Savings Accounts 47779 4
(Date:11/21/2009)...ental Group merges their practice with that of E. ... (PRWEB) November 21, 2009 -- The N...avid Gibson, Dr. Dean Cloutier, Dr. John Plachtyna...owing practice with that of esteemed colleague Dr....e wanted to retire from dentistry in order to conc...
(Date:11/20/2009)...RNewswire-FirstCall/ - NUCRYST Pharmaceuticals Cor...holders will be held on Monday, December 21, 2009....l of two special resolutions. The first special re...ll or substantially all of the assets of NUCRYST, ...et purchase agreement dated November 10, 2009 amon...
(Date:11/20/2009)...Newswire/ -- Following a recall by Unilever The St...e Shedd,s Country Crock ® Side Dishes DELUXE ...174; Side Dishes DELUXE Four Cheese Pasta due to a...g code dates and UPCs are affected: ,, Shedd,s...roccoli Rice 21 oz, UPC 027400218316, Best By NOV ...
(Date:11/20/2009)...re-USNewswire/ -- The American Dental Association ...ation (FDA) to establish appropriate classificatio...ncern about the safety of whitening products that ...essional consultation or examination by a dentist,...ically based tooth whitening or bleaching agents c...
(Date:11/20/2009)...20 Samuel Gladding is n... it means to be "happy" during the holidays. As a ...n family counseling and chair of the Department of...ys research shows that it is the pressure to be ha...n during the holidays. ,, That,s why he,s chall...
Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2
...ames Smith, a former psychiatric patient has been ...Robertson to death in October last year in a Glasg...s than a year after being // released from a psych...gow, befriended James Smith while they were both p...
...he rate of Caesarean sections in the US has climbe...em down. According to the National Center for...ere performed in 2004—29.1 // percent of all birth...time pregnancies with a full-term, single child. T...
... revolutionary research study hints at the evidenc...y offer protection from axonal injury and induced ...sing remitting multiple sclerosis (RRMS). // ... in relapsing remitting multiple sclerosis. The mo...
...n Association for International Cancer Research te...natural compound found in glucose blocks the devel...vital in fighting cancer and // related illnesses....umor by blocking blood and nutrient supply to it. ...
...ondon: A complex natural sugar could be the answer...ex natural sugar from the glucose family that bloc...s online edition of New Scientist. // The te...ts, the sugar molecules were divided and purified ...
...esearchers have found that co-infection of two gen...ake the patients susceptible to malarial parasite ...mia and Patients with Sickle Cell anemia were resi...dings of the research were presented in the Fourth...
Other Medicine News:Health News:Man Bludgeons Friend, Gets Life Term 2Health News:Caesareans In U.S. At All-Time High 2Health News:Help at hand for RRMS patients 2Health News:Co-infection of Two genetic diseases makes them susceptible to malaria 2Health News:Co-infection of Two genetic diseases makes them susceptible to malaria 3Health News:Co-infection of Two genetic diseases makes them susceptible to malaria 4
Cholesterol/HDL Standard
HDL Cholesterol
Ammonia Reagent
...tions over a wide range of concentration, temperat...gh characterization than other methods. Its unique...e in the distribution of molecular weights, provid...ichiometry and self-associating systems. The Prote...
Medicine Products: